Long time followers may remember that we covered the announcement of a French company, Synapse Medicine, launching their Medication Reconciliation and Pharmacovigilance solutions in the US.  I always find it exciting when the US can benefit from technology and solutions that are already having an impact internationally.  At the HIMSS 2022 conference, I was able to sit down with Dr. Clement Goehrs, MD-PhD, CEO & Co-Founder Synapse Medicine, to learn more about their solutions and their expansion into the US.  

Learn more about Synapse Medicine: https://synapse-medicine.com/  

Find more great health IT content: https://www.healthcareittoday.com/